[1]
Zlatkina, V.V., Nesen, A.O. and Demikhova, N. V. 2025. Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1: Pathophysiology and key clinical studies. Ukrainian Journal of Nephrology and Dialysis. 4(88) (Dec. 2025), 88-97. DOI:https://doi.org/10.31450/ukrjnd.4(88).2025.10.